Royal Bank of Canada lowers price target for Zimmer Biomet (NYSE:ZBH) to $130.00
Zimmer Biomet (NYSE:ZBH – Get Free Report) The price target was cut by research analysts at Royal Bank of Canada from $140.00 to $130.00 in a research note published on…